Roku (NASDAQ:ROKU | ROKU Price Prediction) is the streaming name everyone wants to talk about after a 64.41% EPS beat and a 79.82% one-year run. But here’s what you should actually be watching. Roku ...

Iovance focuses on developing tumor-infiltrating lymphocytes (TILs) for cancer treatment. The company has reached the commercialization stage, with melanoma treatment Amtagvi as its flagship drug.

At current prices, CVS Health has a forward dividend yield of around 2.9%. That is considerably higher than UnitedHealth's ...

Iran stops negotiations… how high could oil go?… Jonathan Rose’s three IPO red flags… Elizabeth Warren pushes AI taxes and ...